110 related articles for article (PubMed ID: 10825024)
1. Antigen presentation in the immune response to infectious diseases.
Pamer EG
Clin Infect Dis; 1999 Apr; 28(4):714-6. PubMed ID: 10825024
[TBL] [Abstract][Full Text] [Related]
2. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
[TBL] [Abstract][Full Text] [Related]
3. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
4. A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules.
Rajagopal D; Bal V; Mayor S; George A; Rath S
Eur J Immunol; 2006 Apr; 36(4):828-41. PubMed ID: 16552710
[TBL] [Abstract][Full Text] [Related]
5. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation and recognition in bacterial infections.
Kaufmann SH; Schaible UE
Curr Opin Immunol; 2005 Feb; 17(1):79-87. PubMed ID: 15653315
[TBL] [Abstract][Full Text] [Related]
7. MHC class I antigen presentation--recently trimmed and well presented.
Flutter B; Gao B
Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
[TBL] [Abstract][Full Text] [Related]
8. Translating cell biology in vitro to immunity in vivo.
Boes M; Ploegh HL
Nature; 2004 Jul; 430(6996):264-71. PubMed ID: 15241425
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in antigen processing and presentation.
Jensen PE
Nat Immunol; 2007 Oct; 8(10):1041-8. PubMed ID: 17878914
[TBL] [Abstract][Full Text] [Related]
10. Stress presents a problem for dendritic cells: corticosterone and the fate of MHC class I antigen processing and presentation.
Truckenmiller ME; Bonneau RH; Norbury CC
Brain Behav Immun; 2006 May; 20(3):210-8. PubMed ID: 16504465
[TBL] [Abstract][Full Text] [Related]
11. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
12. New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.
Haque A; Blum JS
J Biol Regul Homeost Agents; 2005; 19(3-4):93-104. PubMed ID: 16602623
[TBL] [Abstract][Full Text] [Related]
13. Toward a molecular explanation for cross-presentation of antigens to the immune system.
Khor B; Makar RS
Transfus Med Rev; 2008 Jul; 22(3):188-201. PubMed ID: 18572095
[TBL] [Abstract][Full Text] [Related]
14. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.
Engelhard VH; Bullock TN; Colella TA; Mullins DW
Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498
[TBL] [Abstract][Full Text] [Related]
15. Lack of fair play in the T cell response.
Lanzavecchia A
Nat Immunol; 2002 Jan; 3(1):9-10. PubMed ID: 11753400
[No Abstract] [Full Text] [Related]
16. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
Holling TM; Schooten E; van Den Elsen PJ
Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
19. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation.
Anderson HA; Hiltbold EM; Roche PA
Nat Immunol; 2000 Aug; 1(2):156-62. PubMed ID: 11248809
[TBL] [Abstract][Full Text] [Related]
20. Cross-presentation in viral immunity and self-tolerance.
Heath WR; Carbone FR
Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
